Search research articles
Contact Us
Filters
Showing results (81-90 of 337) with videos related to
Page
of 34
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
December 8, 2019
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations
Rianne A Weersink, David M Burger, Kelly L Hayward, et al.
International Journal of Antimicrobial Agents
|
June 16, 2014
Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers
Birgit S Jacobs, Angela P H Colbers, Kirsten Velthoven-Graafland, et al.
Biomedical Chromatography : BMC
|
November 24, 2019
Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS
Stefanie D Krens, Eric van der Meulen, Frank G A Jansman, et al.
International Journal of Clinical Pharmacy
|
March 7, 2020
Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Femke Besemer, Cornelis Kramers, Kees Brinkman, et al.
British Journal of Clinical Pharmacology
|
October 27, 2017
Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice
Tessa E H Römkens, Rene Te Morsche, Wilbert Peters, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2018
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
Pieter J Glerum, Yang Yu, Walter M Yamada, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
September 21, 2012
Inadvertent intravenous polyethylene glycol 4000 infusion in a child
Anke Nijkamp, Roel L F van der Palen, Jos M T Draaisma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 10, 2002
Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?
David M Burger, Marijke C Siebers, Patricia W H Hugen, et al.
Antiviral Therapy
|
May 11, 2011
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir
Clara T M M de Kanter, Monique Keuter, Manon J van der Lee, et al.
The Journal of Antimicrobial Chemotherapy
|
November 26, 2009
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
Roger J M Brüggemann, N M A Blijlevens, David M Burger, et al.
Page
of 34
Search research articles
Search
Showing results (81-90 of 337) with videos related to
Sort By:
Page
of 34
Expert Opinion on Drug Metabolism & Toxicology
|
December 8, 2019
Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations
Rianne A Weersink, David M Burger, Kelly L Hayward, et al.
International Journal of Antimicrobial Agents
|
June 16, 2014
Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers
Birgit S Jacobs, Angela P H Colbers, Kirsten Velthoven-Graafland, et al.
Biomedical Chromatography : BMC
|
November 24, 2019
Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS
Stefanie D Krens, Eric van der Meulen, Frank G A Jansman, et al.
International Journal of Clinical Pharmacy
|
March 7, 2020
Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Femke Besemer, Cornelis Kramers, Kees Brinkman, et al.
British Journal of Clinical Pharmacology
|
October 27, 2017
Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice
Tessa E H Römkens, Rene Te Morsche, Wilbert Peters, et al.
Clinical Pharmacology and Therapeutics
|
January 14, 2018
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
Pieter J Glerum, Yang Yu, Walter M Yamada, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
September 21, 2012
Inadvertent intravenous polyethylene glycol 4000 infusion in a child
Anke Nijkamp, Roel L F van der Palen, Jos M T Draaisma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 10, 2002
Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?
David M Burger, Marijke C Siebers, Patricia W H Hugen, et al.
Antiviral Therapy
|
May 11, 2011
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir
Clara T M M de Kanter, Monique Keuter, Manon J van der Lee, et al.
The Journal of Antimicrobial Chemotherapy
|
November 26, 2009
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
Roger J M Brüggemann, N M A Blijlevens, David M Burger, et al.
Page
of 34